共 76 条
[1]
Jemal A(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
[2]
Siegel R(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267-277
[3]
Ward E(2007)MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA. 297 1901-1908
[4]
Hao Y(2008)MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival J Gastrointest Surg 12 2171-2176
[5]
Xu J(2006)Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection Pancreas 33 246-249
[6]
Thun MJ(2009)CA19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent J Gastrointest Surg 13 349-353
[7]
Oettle H(2001)Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial J Clin Oncol 19 3447-3455
[8]
Post S(1994)Disappearance curves of tumor markers after radical surgery Int J Biol Markers 9 33-37
[9]
Neuhaus P(1987)A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373-383
[10]
Bloomston M(1998)Prognostic value of CA19-9 serum course in pancreatic cancer Hepatogastroenterology 45 253-259